Aurora Spine Corporation Stock price

Equities

ASG

CA05206X1087

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. 03:59:50 2024-03-28 pm EDT 5-day change 1st Jan Change
0.395 CAD +16.18% Intraday chart for Aurora Spine Corporation +19.70% -1.25%
Sales 2021 10.54M 14.29M Sales 2022 14.88M 20.16M Capitalization 22.39M 30.35M
Net income 2021 -2M -2.71M Net income 2022 -1M -1.36M EV / Sales 2021 1.67 x
Net cash position 2021 627K 850K Net Debt 2022 2.55M 3.45M EV / Sales 2022 1.68 x
P/E ratio 2021
-6.79 x
P/E ratio 2022
-14.9 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 79.26%
More Fundamentals * Assessed data
Dynamic Chart
Aurora Spine on 2nd Anniversary of Implantation of First Bone Density Matched DEXA-C Cervical Interbody Fusion Device MT
Aurora Spine's Second Patent Related To DEXA Technology Patient-Matched Implant Technology Issued by U.S. Patent Office MT
Aurora Spine Corp Granted New US Patent MT
Aurora Spine Corporation to Showcase Sacroiliac Joint (Si Joint) Fusion Products At North American Neuromodulation Society Annual Meeting CI
Aurora Spine Corp Announces Published Paper on First 6-month Clinical Evaluation of its ZIP Fusion Implant MT
Aurora Spine Corporation Announces Newly Published Paper on First 6-Month Clinical Evaluation of its ZIP?? Fusion Implant CI
Aurora Spine Corp Announces Q3 2023 Results MT
Transcript : Aurora Spine Corporation, Q3 2023 Earnings Call, Nov 15, 2023
Aurora Spine Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Aurora Spine Corporation announced that it has received CAD 1.933782 million in funding CI
Aurora Spine Announces Full Release of its SiLO TFX MIS Sacroiliac Joint Fixation System MT
Aurora Spine Corporation Announces Full Release of its SiLO TFX?? MIS Sacroiliac Joint Fixation System CI
Transcript : Aurora Spine Corporation, Q2 2023 Earnings Call, Aug 29, 2023
Aurora Spine Reports Q2 2023 Net Loss of US$0.01 Per Share MT
Aurora Spine Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
More news
1 day+16.18%
1 week+19.70%
Current month+19.70%
1 month+23.44%
3 months+6.76%
6 months+6.76%
Current year-1.25%
More quotes
1 week
0.32
Extreme 0.32
0.40
1 month
0.28
Extreme 0.28
0.40
Current year
0.28
Extreme 0.28
0.40
1 year
0.23
Extreme 0.23
0.47
3 years
0.22
Extreme 0.22
0.84
5 years
0.00
Extreme 0
1.04
10 years
0.00
Extreme 0
5.15
More quotes
Managers TitleAgeSince
Founder 53 13-07-03
Founder 56 13-07-03
Director of Finance/CFO - 18-12-31
Members of the board TitleAgeSince
Director/Board Member 61 13-07-03
Chairman 66 13-07-03
Founder 56 13-07-03
More insiders
Date Price Change Volume
24-03-28 0.395 +16.18% 28,500
24-03-27 0.34 +1.49% 500
24-03-26 0.335 +4.69% 10,600
24-03-25 0.32 -3.03% 1,000
24-03-22 0.33 0.00% 5,500

Delayed Quote Toronto S.E., March 28, 2024 at 03:59 pm EDT

More quotes
Aurora Spine Corporation is a designer and manufacturer of medical devices. The Company is engaged in the development and distribution of minimally invasive, interspinous fusion systems and devices. Its product line includes implants, surgical tools and biologics. Its implants include Cervical Products, Thoraco-Lumbar Products, and SI joint products. The surgical tools include Anterior Disc Prep, Posterior Disc Prep and Compass 4D Retractor System. The biologics consist of ZIP Graft and SiLO Si-Fusion. The Company is focused on DEXA technology, which opens up treatment for osteoporotic patients. It offers DEXA-C Cervical Implants Featuring Visual Density Markers, and DEXA -L Standalone Anterior Lumbar Interbody Fusion System.
More about the company
  1. Stock
  2. Equities
  3. Stock Aurora Spine Corporation - Toronto S.E.